Abstract
Dornase alfa is the first new drug released in 30 years for the treatment of patients with CF. Although it does not represent a replacement for current standard therapies, it is an effective agent in improving lung function. The development of this drug has helped to provide treatment to a medical problem that physicians have struggled with treating for years.
Original language | English |
---|---|
Pages (from-to) | 278-279 |
Number of pages | 2 |
Journal | Pediatric nursing |
Volume | 20 |
Issue number | 3 |
State | Published - May 1994 |
ASJC Scopus subject areas
- Pediatrics